Bio Green Med Solution, Inc. BGMS
Biotechnology: Pharmaceutical Preparations · data as of November 13, 2026
Bio Green Med Solution, Inc. (BGMS) is a healthcare company listed in the US with a market value of about $4M. In the twelve months to September 30, 2026 it had revenue of $2M and net income of -$2M, a net margin of -74.4%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is financial health (2/5); the weakest is track record (0/5).
Key numbers: a 5-year average ROIC of -944%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 19% above the current price.
About Bio Green Med Solution
Bio Green Med Solution is listed in the US and classified in biotechnology: pharmaceutical preparations. Revenue went from $150000 in 2018 to $43000 in 2024, a decline of about 18.8% a year. It was profitable in 0 of the last 8 years in our data. Its share count rose by 19313% over three years (dilution for shareholders).
Score: 0.8 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- Strong R&D investment or growth above 20%
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 8 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | $0 | $43000 | $420000 | $0 | $0 | $0 | — | $150000 |
| Net income | -$2M | -$3M | -$11M | -$23M | -$21M | -$18M | -$8M | -$8M | -$7M |
| Free cash flow | — | — | — | -$16M | -$21M | -$19M | -$8M | -$9M | -$7M |
| EPS (diluted) | $-0.25 | $-2.15 | $-167.49 | $-2139726.67 | $-9080.00 | $-696.67 | $-1140.00 | $-3280.00 | $-4133.37 |
| Net margin | -74.4% | — | -26074.4% | -5370.2% | — | — | — | — | -4858.7% |
| ROIC | — | -97.0% | — | -3488.9% | -141.0% | -49.4% | -27.0% | -64.5% | -52.8% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Bio Green Med Solution stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 19% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Bio Green Med Solution pay a dividend?
Not currently.
Is Bio Green Med Solution a good stock to buy?
We do not give buy or sell advice. Bio Green Med Solution scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.